TBIO (Telesis Bio) Shares Outstanding (EOP): 1.77 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TBIO Telesis Bio Inc TBIO
12 GF Score
Price $0.00
View Full Analysis

What is Telesis Bio Shares Outstanding (EOP)?

Telesis Bio TBIO 12 Shares Outstanding (EOP) is 1.77 Mil as of Jun. 2024. GuruFocus rates TBIO with a GF Score™ of 12/100.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Telesis Bio's shares outstanding for the quarter that ended in Jun. 2024 was 1.77 Mil.

Telesis Bio's quarterly shares outstanding stayed the same from Mar. 2024 (1.77 Mil) to Jun. 2024 (1.77 Mil).

Telesis Bio's annual shares outstanding increased from Dec. 2022 (1.64 Mil) to Dec. 2023 (1.66 Mil). It means Telesis Bio issued new shares from Dec. 2022 to Dec. 2023 .


Telesis Bio  (OTCPK:TBIO) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Telesis Bio Shares Outstanding (EOP) Related Terms


Telesis Bio Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Telesis Bio's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telesis Bio Shares Outstanding (EOP) Chart

Telesis Bio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
0.00 1.77 1.01 1.64 1.66

Telesis Bio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.65 1.66 1.67 1.77 1.77

TBIO vs MHTX, ABT, BSX: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, Telesis Bio's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telesis Bio Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Telesis Bio's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Telesis Bio's Shares Outstanding (EOP) falls into.


TBIO
12GF Score
Telesis Bio Inc TBIO
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Telesis Bio Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 1.77 Mil mean?
Telesis Bio (TBIO) has a Shares Outstanding (EOP) of 1.77 Mil as of Jun. 2024. The total shares a company has outstanding, at period-end. View historical data on Telesis Bio and its competitors.
Is Telesis Bio's Shares Outstanding (EOP) too high?
Telesis Bio's current Shares Outstanding (EOP) is 1.77 Mil. Overall, Telesis Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Telesis Bio's Shares Outstanding (EOP) compare to MHTX and ABT?
Telesis Bio's Shares Outstanding (EOP) of 1.77 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Telesis Bio and its competitors. Telesis Bio's current Shares Outstanding (EOP) is 1.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telesis Bio stock overvalued right now?
Telesis Bio (TBIO) has a current Shares Outstanding (EOP) of 1.77 Mil. The current Shares Outstanding (EOP) is 1.77 Mil. Telesis Bio's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Telesis Bio (TBIO), the current Shares Outstanding (EOP) is 1.77 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Telesis Bio Business Description

Address 10431 Wateridge Circle, Suite 150, San Diego, CA, USA, 92121
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.
12GF Score

Get the complete analysis for TBIO

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price